Cuban Meningococcal BC Vaccine: Experiences & Contributions from 20 Years of Application
Fuente:
Redalyc
Enregistré dans:
| Auteur principal: | Franklin Sotolongo Padrón |
|---|---|
| Format: | Artículo científico |
| Langue: | en |
| Publié: |
Medical Education Cooperation with Cuba
2007
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Conjugated vaccines against serogroup A, C, W-135 and y disease
par: Marcos Aurelio P. Sáfadi
Publié: (2009)
par: Marcos Aurelio P. Sáfadi
Publié: (2009)
Effectiveness of a Serogroup B and C Meningococcal Vaccine Developed in Cuba
par: Rolando F. Ochoa-Azze
Publié: (2018)
par: Rolando F. Ochoa-Azze
Publié: (2018)
Economic evaluation of meningococcal vaccination with vaccine for serogroups A, C, W e Y: A systematic revision
par: Matos, Beatriz Tomás de, et autres
Publié: (2023)
par: Matos, Beatriz Tomás de, et autres
Publié: (2023)
The New Generation of Meningococcal Conjugate Vaccines: Rationale and Global Potential
par: Jacqueline Miller
Publié: (2009)
par: Jacqueline Miller
Publié: (2009)
Vaccine: X
Publié: (2019)
Publié: (2019)
No Needles, No Pain - Edible Vaccines as an Alternative to Traditional Vaccination Methods
par: Kinga Cogiel, et autres
Publié: (2025)
par: Kinga Cogiel, et autres
Publié: (2025)
npj Vaccines
Publié: (2017)
Publié: (2017)
Vaccine Research
Publié: (2020)
Publié: (2020)
Эпидемиология и вакцинопрофилактика
Publié: (2019)
Publié: (2019)
Safety and Immunogenicity of Cuban Antipneumococcal Conjugate Vaccine PCV7-TT in Healthy Adults
par: Nadezhda González
Publié: (2015)
par: Nadezhda González
Publié: (2015)
Vaccinating with a COVID-19 Vaccine: Experience of the Tertiary Allergology Center
par: Eglė Žilėnaitė*
Publié: (2022)
par: Eglė Žilėnaitė*
Publié: (2022)
Infectious Bursal Disease: Evaluation of Pathogenicity of Commercial Vaccines from Brazil in Specific Pathogen Free Chichens
par: HLS Moraes
Publié: (2004)
par: HLS Moraes
Publié: (2004)
Infectious Bursal Disease: Evaluation of Pathogenicity of Commercial Vaccines from Brazil in Specific Pathogen Free Chichens (ERRATA)
par: HLS Moraes
Publié: (2005)
par: HLS Moraes
Publié: (2005)
Effect of Associated Vaccines on the Interference between Newcastle Disease Virus and Infectious Bronchitis Virus in Broilers
par: WM Cardoso
Publié: (2005)
par: WM Cardoso
Publié: (2005)
Epidemiological Findings of Neurocryptococcosis in Immunocompetent Patients: Case Reports from a Public Hospital in Joinville, Brazil
par: Camila Ribeiro Batista Rudnik
Publié: (2020)
par: Camila Ribeiro Batista Rudnik
Publié: (2020)
Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de cuatro componentes
par: A. Gil
Publié: (2014)
par: A. Gil
Publié: (2014)
Alternative method using Real Time PCR for evaluation of inactivated Newcastle disease viral vaccine
par: Mounir El Safty
Publié: (2023)
par: Mounir El Safty
Publié: (2023)
Meningitis recurrente en el adulto: un reto diagnóstico y terapéutico
par: Basilio Vagner Ramírez
Publié: (2010)
par: Basilio Vagner Ramírez
Publié: (2010)
Expert Review of Vaccines
Publié: (2023)
Publié: (2023)
Múltiples infecciones oportunistas concurrentes al sistema nervioso central en paciente VIH positivo y su respuesta al TARGA: reporte de un caso.
par: José Luis Conde-Salazar
Publié: (2013)
par: José Luis Conde-Salazar
Publié: (2013)
Facing Alzheimer’s disease in the developing countries.
par: Dante J. Marciani
Publié: (2017)
par: Dante J. Marciani
Publié: (2017)
Newcastle Disease in White Pekin Ducks: Response to Experimental Vaccination and Challenge
par: M Nishizawa
Publié: (2007)
par: M Nishizawa
Publié: (2007)
Efficacy of current vaccines against recently isolated foot and mouth disease virus type A South America (Venezuela) in Egypt 2022
par: Shafik Nermeen G
Publié: (2024)
par: Shafik Nermeen G
Publié: (2024)
Diagnóstico Etiológico de Meningitis Bacteriana en Lactantes. Hospital “José María Benitez”, La Victoria. Venezuela.
par: Ana Cedeño
Publié: (2008)
par: Ana Cedeño
Publié: (2008)
Economics of eradicating Foot-and-Mouth disease epidemics with alternative control strategies
par: RHM Bergevoet
Publié: (2014)
par: RHM Bergevoet
Publié: (2014)
BURSAL RESTORATION AFTER INTERMEDIATE AND INTERMEDIATE PLUS INFECTIOUS BURSAL DISEASE VIRUS VACCINATION
par: María Castro
Publié: (2009)
par: María Castro
Publié: (2009)
Avian Cytokines in Health and Disease
par: P Wigley
Publié: (2003)
par: P Wigley
Publié: (2003)
Caracterización de cepas de Neisseria meningitidis causantes de enfermedad invasiva en Cuba
par: Nirtza Suárez Navarro
Publié: (2014)
par: Nirtza Suárez Navarro
Publié: (2014)
Enfermedad neumocócica invasiva en la era posvacunal: Reporte de un caso
par: Edwin Albino H. Miranda Choque
Publié: (2016)
par: Edwin Albino H. Miranda Choque
Publié: (2016)
Vaccine-Related Adverse Events in Cuban Children, 1999–2008
par: Belkys M. Galindo
Publié: (2012)
par: Belkys M. Galindo
Publié: (2012)
Design of recombinant vaccines for Gumboro, Newcastle and Avian Infectious Laryngotracheitis
par: Andrés Felipe Santander Torres
Publié: (2014)
par: Andrés Felipe Santander Torres
Publié: (2014)
Инфекция и иммунитет
Publié: (2015)
Publié: (2015)
Clinical and Experimental Vaccine Research
Publié: (2018)
Publié: (2018)
Tropical Diseases, Travel Medicine and Vaccines
Publié: (2016)
Publié: (2016)
Versuche zur Impfung von Regenbogenforellen gegen Vibrio
Publié: (1979)
Publié: (1979)
Cuba’s Scientific Contributions to Global Polio Eradication
par: Sonia Resik
Publié: (2018)
par: Sonia Resik
Publié: (2018)
Meningitis por Listeria monocytogenes en paciente inmunocompetente
par: Carlos Morell Úbeda
Publié: (2016)
par: Carlos Morell Úbeda
Publié: (2016)
Reporte de un caso clínico de holoprosencefalia
par: Lissette Chan-Guevara
Publié: (2006)
par: Lissette Chan-Guevara
Publié: (2006)
Características epidemiológicas de la mortalidad por meningitis bacteriana en Paraguay (2015 - 2019)
par: Myrian Elizabeth Rivas-Kiese
Publié: (2022)
par: Myrian Elizabeth Rivas-Kiese
Publié: (2022)
Infectious Microbes & Diseases
Publié: (2021)
Publié: (2021)
Documents similaires
-
Conjugated vaccines against serogroup A, C, W-135 and y disease
par: Marcos Aurelio P. Sáfadi
Publié: (2009) -
Effectiveness of a Serogroup B and C Meningococcal Vaccine Developed in Cuba
par: Rolando F. Ochoa-Azze
Publié: (2018) -
Economic evaluation of meningococcal vaccination with vaccine for serogroups A, C, W e Y: A systematic revision
par: Matos, Beatriz Tomás de, et autres
Publié: (2023) -
The New Generation of Meningococcal Conjugate Vaccines: Rationale and Global Potential
par: Jacqueline Miller
Publié: (2009) -
Vaccine: X
Publié: (2019)